PharmaTutor Magazine - October 2017 is released | Subscribe today
Spinach (palak) got patented for prevention and /or treatment of bone related disorders
A first ever breakthrough in the area of osteoarthritis, a most common chronic condition of the joints that afflicts mainly the weight-bearing joints such as hips and knees, and causes physical disabilities. At present there is no viable treatment available for osteoarthritis. CDRI (Central Drug Research Institute) Scientists has developed a standardized nano-formulation from Spinaceaoleracea commonly known as Palak for treatment of osteoarthritis. And it is patented for formulation of Spinaceaoleracea for the prevention and /or treatment of bone related disorders by CDRI.
Osteoarthritis may be considered as a problem of old age but in contrast it is the most common form of joint disease, that can strike in younger age groups too. Most people think arthritis is an inevitable part of ageing, but in fact, it can affect anyone at any age, Regardless of age, the condition can have a significant negative impact on healthy life.
In India ~39% people suffer from Osteoarthritis. Out of this 45% of women above 65 years experience symptoms and 70% of them have x-ray evidence of Osteoarthritis. Postmenopausal women with osteoarthritis have a 20% increased risk of fracture.
Many factors can contribute to the development of the condition, including genetics, weight and joint injury. Wear and tear injuries can be common, and joint pain is something many, if not most, people will experience at certain points.
At present there are no drugs in the market especially any orally available drug for osteoarthritis. Only symptomatic treatments are available with pain killers like ibuprofen, naproxen. There are reports that these drugs on long term use show liver toxicity.